REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Mailing of Notice of 2025 Annual Meeting

Mycelx TechnologiesAnnouncement

22/08/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250822:nRSV1194Wa&default-theme=true

RNS Number : 1194W  MyCelx Technologies Corporation  22 August 2025

22 August 2025

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Mailing of Notice of 2025 Annual Meeting

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology company, announces that, following the mailing to
shareholders on 10 June 2025 of the Company's 2024 Annual Report, the Notice
of 2025 Annual Meeting is today being mailed to shareholders.

 

Copies have been placed on the Company's website at www.mycelx.com
(http://www.mycelx.com) . Copies will also be available free of charge from
the Company's headquarters at 1650 International Court, Suite 100, Norcross,
Georgia, USA 30093 for a period of at least one month.

 

Annual Meeting

 

As previously announced, the Company's 2025 Annual Meeting will be held at
2:00 p.m. (BST) on Tuesday 23 September 2025 at the offices of Cavendish
Capital Markets Limited, One Bartholomew Close, London, EC1A 7BL.

 

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                                      Tel: +1 888 306 6843

 Kim Slayton, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

 Giles Balleny / Callum Davidson (Corporate Finance)                    Tel: +44 20 7220 0500

 Jamie Anderson (Corporate Broking)

 Jasper Berry / Michael Johnson (Sales)

 Celicourt Communications (Financial PR)

 Mark Antelme                                                           Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAPPUPWRUPAGGU